The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency

Genes and Immunity

Volumn 10, Issue 2, 2009, Pages 151-161

  Haimila, K ^a   Einarsdottir, E ^b   de Kauwe, A ^b   Koskinen, L L E ^b   Pan Hammarstrom Q ^c   Kaartinen, T ^a   Kurppa, K ^d   Ziberna, F ^e   Not, T ^e   Vatta, S ^e   Ventura, A ^f   Korponay Szabo, I R ^g   Adany R ^g   Pocsai, Z ^g   Szeles G ^g   Dukes, E ^b   Kaukinen, K ^d   Maki M ^d   Koskinen, S ^a   Partanen, J ^a   Hammarstrom L ^c   Saavalainen, P ^b   more..

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e UNIVERSITY OF TRIESTE   (Italy)

^f UNIVERSITY OF DEBRECEN   (Hungary)

^g UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GENE PRODUCT; INDUCIBLE CO STIMULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELIAC DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FINLAND; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUNGARY; IMMUNOGLOBULIN A DEFICIENCY; ITALY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELIAC DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FINLAND; GENOTYPE; HUMANS; HUNGARY; IGA DEFICIENCY; LINKAGE (GENETICS); MALE; QUANTITATIVE TRAIT LOCI;

EID: 61849126866     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.89     Document Type: Article

References (52)

1. Collin P, Maki M, Keyrilainen O, Hallstrom O, Reunala T, Pasternack A. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol 1992; 27: 367-371.
2. Koskinen S. Long-term follow-up of health in blood donors with primary selective IgA deficiency. J Clin Immunol 1996; 16: 165-170.
3. Latiff AH, Kerr MA. The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem 2007; 44: 131-139.
4. Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000; 120: 225-231.
5. Aghamohammadi A, Mohammadi J, Parvaneh N, Rezaei N, Moin M, Espanol T et al. Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol 2008; 147: 87-92.
6. Vorechovsky I, Zetterquist H, Paganelli R, Koskinen S, Webster AD, Bjorkander J et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 1995; 77: 185-192.
7. Koistinen J. Familial clustering of selective IgA deficiency. Vox Sang 1976; 30: 181-190.
8. Gerbase-Delima M, Pinto LC, Grumach A, Carneiro-Sampaio MM. HLA antigens and haplotypes in IgA-deficient Brazilian paediatric patients. Eur J Immunogenet 1998; 25: 281-285.
9. Schroeder Jr HW, Zhu ZB, March RE, Campbell RD, Berney SM, Nedospasov SA et al. Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med 1998; 4: 72-86.
10. Vorechovsky I, Webster AD, Plebani A, Hammarstrom L. Genetic linkage of IgA deficiency to the major histocompatibility complex: Evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 1999; 64: 1096-1109.
11. Czyzewska-Buczynska A, Majkowska-Skrobek G, Jankowski A. Association of HLA-*08:DRB1*03 with immunoglobulin A-deficiency. Indian J Pediatr 2007; 74: 1021-1024.
12. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999; 167: 257-274.
13. Gough SC, Walker LS, Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunol Rev 2005; 204: 102-115.
14. Popat S, Hearle N, Hogberg L, Braegger CP, O'Donoghue D, Falth-Magnusson K et al. Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease. Ann Hum Genet 2002; 66: 125-137.
15. van Heel DA, Hunt K, Greco L, Wijmenga C. Genetics in coeliac disease. Best Pract Res Clin Gastroenterol 2005; 19: 323-339.
16. Holopainen P, Arvas M, Sistonen P, Mustalahti K, Collin P, Maki M et al. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study. Tissue Antigens 1999; 53: 470-475.
17. Haimila K, Smedberg T, Mustalahti K, Maki M, Partanen J, Holopainen P. Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33. Genes Immun 2004; 5: 85-92.
18. Shilling RA, Bandukwala HS, Sperling AI. Regulation of T:B cell interactions by the inducible costimulator molecule: Does ICOS 'induce' disease? Clin Immunol 2006; 121: 13-18.
19. Yamada A, Salama AD, Sayegh MH. The role of novel T cell costimulatory pathways in autoimmunity and transplantation. J Am Soc Nephrol 2002; 13: 559-575.
20. Jahromi MM, Eisenbarth GS. Genetic determinants of type 1 diabetes across populations. Ann NY Acad Sci 2006; 1079: 289-299.
21. Chistiakov DA, Turakulov RI. CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol 2003; 31: 21-36.
22. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4: 261-268.
23. Salzer U, Maul-Pavicic A, Cunningham-Rundles C, Urschel S, Belohradsky BH, Litzman J et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 2004; 113: 234-240.
24. Amundsen SS, Naluai AT, Ascher H, Ek J, Gudjonsdottir AH, Wahlstrom J et al. Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease. Tissue Antigens 2004; 64: 593-599.
25. Zhernakova A, Eerligh P, Barrera P, Wesoly JZ, Huizinga TW, Roep BO et al. CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum Genet 2005; 118: 58-66.
26. Kaartinen T, Lappalainen J, Haimila K, Autero M, Partanen J. Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4. Mol Immunol 2007; 44: 1644-1651.
27. Butty V, Roy M, Sabeti P, Besse W, Benoist C, Mathis D. Signatures of strong population differentiation shape extended haplotypes across the human CD28, CTLA4, and ICOS costimulatory genes. Proc Natl Acad Sci USA 2007; 104: 570-575.
28. Holopainen P, Naluai AT, Moodie S, Percopo S, Coto I, Clot F et al. Candidate gene region 2q33 in European families with coeliac disease. Tissue Antigens 2004; 63: 212-222.
29. Mora B, Bonamico M, Indovina P, Megiorni F, Ferri M, Carbone MC et al. CTLA-4 +49 A/G dimorphism in Italian patients with celiac disease. Hum Immunol 2003; 64: 297-301.
30. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot JF, Bach JF, Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 1998; 43: 187-189.
31. Naluai AT, Nilsson S, Samuelsson L, Gudjonsdottir AH, Ascher H, Ek J et al. The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders. Tissue Antigens 2000; 56: 350-355.
32. Capilla A, Donat E, Planelles D, Espinos C, Ribes-Koninckx C, Palau F. Genetic analyses of celiac disease in a Spanish population confirm association with CELIAC3 but not with CELIAC4. Tissue Antigens 2007; 70: 324-329.
33. van Belzen MJ, Mulder CJ, Zhernakova A, Pearson PL, Houwen RH, Wijmenga C. CTLA4 +49 A/G and CT60 polymorphisms in Dutch coeliac disease patients. Eur J Hum Genet 2004; 12: 782-785.
34. Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C et al. The CTLA4 region as a general autoimmunity factor: An extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur J Hum Genet 2003; 11: 81-84.
35. Bjornvold M, Undlien DE, Joner G, Dahl-Jorgensen K, Njolstad PR, Akselsen HE et al. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia 2008; 51: 589-596.
36. Hunt KA, McGovern DP, Kumar PJ, Ghosh S, Travis SP, Walters JR et al. A common CTLA4 haplotype associated with coeliac disease. Eur J Hum Genet 2005; 13: 440-444.
37. van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007; 39: 827-829.
38. Brophy K, Ryan AW, Thornton JM, Abuzakouk M, Fitzgerald AP, McLoughlin RM et al. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population. Genes Immun 2006; 7 19-26.
39. Howard TD, Postma DS, Hawkins GA, Koppelman GH, Zheng SL, Wysong AK et al. Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J Allergy Clin Immunol 2002; 110 743-751.
40. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
41. Hammarstrom L, Persson MA, Smith CI. Anti-IgA in selective IgA deficiency. In vitro effects and Ig subclass pattern of human anti-IgA. Scand J Immunol 1983; 18: 509-513.
42. Valdimarsson T, Franzen L, Grodzinsky E, Skogh T, Strom M. Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults. Dig Dis Sci 1996; 41: 83-87.
43. Collin P, Kaukinen K, Vogelsang H, Korponay-Szabo I, Sommer R, Schreier E et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: A biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 2005; 17: 85-91.
44. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909-911.
45. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: Time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-1194.
46. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119-134.
47. Monsuur AJ, de Bakker PI, Zhernakova A, Pinto D, Verduijn W, Romanos J et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS ONE 2008; 3: E2270.
48. O'Connell JR, Weeks DE. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.
49. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97-101.
50. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.
51. Kruglyak L, Lander ES. Faster multipoint linkage analysis using Fourier transforms. J Comput Biol 1998; 5: 1-7.
52. Purcell S, Cherny SS, Sham PC. Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.